SONO TEK CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that SONO TEK CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $20.50M | May 28, 2025 |
| FY2025 | Feb 29, 2024 | $19.70M | May 28, 2025 |
| FY2024 | Feb 28, 2023 | $15.06M | May 23, 2024 |
| FY2023 | Feb 28, 2022 | $17.13M | May 25, 2023 |
| FY2022 | Feb 28, 2021 | $14.83M | May 24, 2022 |
| FY2021 | Feb 29, 2020 | $15.35M | May 28, 2021 |
| FY2020 | Feb 28, 2019 | $11.61M | May 29, 2020 |
| FY2019 | Feb 28, 2018 | $11.01M | May 28, 2019 |
| FY2018 | Feb 28, 2017 | $9.63M | May 24, 2018 |
| FY2017 | Feb 29, 2016 | $11.83M | May 26, 2017 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Feb 28, 2018 | $6.30M | May 24, 2018 |
| FY2018 | Feb 28, 2017 | $6.05M | May 24, 2018 |
| FY2017 | Feb 29, 2016 | $6.58M | May 26, 2017 |
| FY2016 | Feb 28, 2015 | $5.02M | May 25, 2016 |
| FY2015 | Feb 28, 2014 | $6.45M | May 27, 2015 |
| FY2015 | Feb 28, 2013 | $5.02M | May 27, 2015 |
| FY2012 | Feb 29, 2012 | $7.39M | May 22, 2013 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $9.74M | May 28, 2025 |
| FY2025 | Feb 29, 2024 | $9.84M | May 28, 2025 |
| FY2024 | Feb 28, 2023 | $7.65M | May 23, 2024 |
| FY2023 | Feb 28, 2022 | $8.61M | May 25, 2023 |
| FY2022 | Feb 28, 2021 | $7.00M | May 24, 2022 |
| FY2021 | Feb 29, 2020 | $7.31M | May 28, 2021 |
| FY2020 | Feb 28, 2019 | $5.25M | May 29, 2020 |
| FY2019 | Feb 28, 2018 | $5.30M | May 28, 2019 |
| FY2018 | Feb 28, 2017 | $4.36M | May 24, 2018 |
| FY2017 | Feb 29, 2016 | $5.64M | May 26, 2017 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $1.01M | May 28, 2025 |
| FY2025 | Feb 29, 2024 | $1.18M | May 28, 2025 |
| FY2024 | Feb 28, 2023 | $683.0K | May 23, 2024 |
| FY2023 | Feb 28, 2022 | $1.89M | May 25, 2023 |
| FY2022 | Feb 28, 2021 | $1.34M | May 24, 2022 |
| FY2021 | Feb 29, 2020 | $1.12M | May 28, 2021 |
| FY2020 | Feb 28, 2019 | $82.5K | May 29, 2020 |
| FY2019 | Feb 28, 2018 | $381.6K | May 28, 2019 |
| FY2018 | Feb 28, 2017 | ($178.6K) | May 24, 2018 |
| FY2017 | Feb 29, 2016 | $740.3K | May 26, 2017 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $2.72M | May 28, 2025 |
| FY2025 | Feb 29, 2024 | $2.89M | May 28, 2025 |
| FY2024 | Feb 28, 2023 | $2.15M | May 23, 2024 |
| FY2023 | Feb 28, 2022 | $1.73M | May 25, 2023 |
| FY2022 | Feb 28, 2021 | $1.64M | May 24, 2022 |
| FY2021 | Feb 29, 2020 | $1.43M | May 28, 2021 |
| FY2020 | Feb 28, 2019 | $1.32M | May 29, 2020 |
| FY2019 | Feb 28, 2018 | $1.28M | May 28, 2019 |
| FY2018 | Feb 28, 2017 | $1.28M | May 24, 2018 |
| FY2017 | Feb 29, 2016 | $1.27M | May 26, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $525.0K | May 28, 2025 |
| FY2025 | Feb 29, 2024 | $1.16M | May 28, 2025 |
| FY2024 | Feb 28, 2023 | $1.33M | May 23, 2024 |
| FY2023 | Feb 28, 2022 | $2.32M | May 25, 2023 |
| FY2022 | Feb 28, 2021 | $725.2K | May 24, 2022 |
| FY2021 | Feb 29, 2020 | $3.25M | May 28, 2021 |
| FY2020 | Feb 28, 2019 | ($109.0K) | May 29, 2020 |
| FY2019 | Feb 28, 2018 | $1.80M | May 28, 2019 |
| FY2018 | Feb 28, 2017 | $1.03M | May 24, 2018 |
| FY2017 | Feb 29, 2016 | $628.8K | May 26, 2017 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $468.8K | May 28, 2025 |
| FY2025 | Feb 29, 2024 | $794.7K | May 28, 2025 |
| FY2024 | Feb 28, 2023 | $555.9K | May 23, 2024 |
| FY2023 | Feb 28, 2022 | $326.9K | May 25, 2023 |
| FY2022 | Feb 28, 2021 | $344.4K | May 24, 2022 |
| FY2021 | Feb 29, 2020 | $722.2K | May 28, 2021 |
| FY2020 | Feb 28, 2019 | $547.3K | May 29, 2020 |
| FY2019 | Feb 28, 2018 | $189.2K | May 28, 2019 |
| FY2018 | Feb 28, 2017 | $182.8K | May 24, 2018 |
| FY2017 | Feb 29, 2016 | $465.4K | May 26, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $23.41M | May 28, 2025 |
| FY2025 | Feb 29, 2024 | $23.13M | May 28, 2025 |
| FY2024 | Feb 28, 2023 | $20.17M | May 23, 2024 |
| FY2023 | Feb 28, 2022 | $17.63M | May 25, 2023 |
| FY2022 | Feb 28, 2021 | $16.42M | May 24, 2022 |
| FY2021 | Feb 29, 2020 | $14.74M | May 28, 2021 |
| FY2020 | Feb 28, 2019 | $12.20M | May 29, 2020 |
| FY2019 | Feb 28, 2018 | $11.78M | May 28, 2019 |
| FY2018 | Feb 28, 2017 | $10.74M | May 24, 2018 |
| FY2017 | Feb 29, 2016 | $10.67M | May 26, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $5.62M | May 28, 2025 |
| FY2025 | Feb 29, 2024 | $6.85M | May 28, 2025 |
| FY2024 | Feb 28, 2023 | $5.54M | May 23, 2024 |
| FY2023 | Feb 28, 2022 | $3.88M | May 25, 2023 |
| FY2022 | Feb 28, 2021 | $5.47M | May 24, 2022 |
| FY2021 | Feb 29, 2020 | $4.96M | May 28, 2021 |
| FY2020 | Feb 28, 2019 | $3.62M | May 29, 2020 |
| FY2019 | Feb 28, 2018 | $3.39M | May 28, 2019 |
| FY2018 | Feb 28, 2017 | $2.81M | May 24, 2018 |
| FY2017 | Feb 29, 2016 | $3.00M | May 26, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $17.79M | May 28, 2025 |
| FY2025 | Feb 29, 2024 | $16.28M | May 28, 2025 |
| FY2025 | Feb 28, 2023 | $14.63M | May 28, 2025 |
| FY2024 | Feb 28, 2022 | $13.74M | May 23, 2024 |
| FY2023 | Feb 28, 2021 | $10.95M | May 25, 2023 |
| FY2022 | Feb 29, 2020 | $9.78M | May 24, 2022 |
| FY2021 | Feb 28, 2019 | $8.58M | May 28, 2021 |
| FY2020 | Feb 28, 2018 | $8.39M | May 29, 2020 |
| FY2019 | Feb 28, 2017 | $7.92M | May 28, 2019 |
| FY2018 | Feb 29, 2016 | $7.67M | May 24, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $7.62M | May 28, 2025 |
| FY2025 | Feb 29, 2024 | $6.35M | May 28, 2025 |
| FY2024 | Feb 28, 2023 | $4.91M | May 23, 2024 |
| FY2023 | Feb 28, 2022 | $4.27M | May 25, 2023 |
| FY2022 | Feb 28, 2021 | $1.73M | May 24, 2022 |
| FY2021 | Feb 29, 2020 | $610.5K | May 28, 2021 |
| FY2020 | Feb 28, 2019 | ($496.9K) | May 29, 2020 |
| FY2019 | Feb 28, 2018 | ($760.1K) | May 28, 2019 |
| FY2018 | Feb 28, 2017 | ($1.13M) | May 24, 2018 |
| FY2017 | Feb 29, 2016 | ($1.22M) | May 26, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $5.20M | May 28, 2025 |
| FY2025 | Feb 29, 2024 | $2.13M | May 28, 2025 |
| FY2024 | Feb 28, 2023 | $3.35M | May 23, 2024 |
| FY2023 | Feb 28, 2022 | $4.84M | May 25, 2023 |
| FY2022 | Feb 28, 2021 | $4.08M | May 24, 2022 |
| FY2021 | Feb 29, 2020 | $3.66M | May 28, 2021 |
| FY2020 | Feb 28, 2019 | $3.14M | May 29, 2020 |
| FY2020 | Feb 28, 2018 | $2.02M | May 29, 2020 |
| FY2019 | Feb 28, 2017 | $2.56M | May 28, 2019 |
| FY2018 | Feb 29, 2016 | $2.39M | May 24, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Feb 28, 2021 | $1.00M | May 28, 2021 |
| FY2021 | Feb 29, 2020 | $707.7K | May 28, 2021 |
| FY2020 | Feb 28, 2019 | $870.5K | May 29, 2020 |
| FY2019 | Feb 28, 2018 | $1.03M | May 28, 2019 |
| FY2018 | Feb 28, 2017 | $1.18M | May 24, 2018 |
| FY2017 | Feb 29, 2016 | $1.32M | May 26, 2017 |
| FY2016 | Feb 28, 2015 | $1.48M | May 25, 2016 |
| FY2015 | Feb 28, 2014 | $1.67M | May 27, 2015 |
| FY2013 | Feb 28, 2013 | $2.11M | May 28, 2014 |
| FY2012 | Feb 29, 2012 | $2.23M | May 22, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | 0 | May 28, 2025 |
| FY2025 | Feb 29, 2024 | 0 | May 28, 2025 |
| FY2024 | Feb 28, 2023 | 0 | May 23, 2024 |
| FY2023 | Feb 28, 2022 | 0 | May 25, 2023 |
| FY2022 | Feb 28, 2021 | 0 | May 24, 2022 |
| FY2021 | Feb 29, 2020 | 0 | May 28, 2021 |
| FY2020 | Feb 28, 2019 | 0 | May 29, 2020 |
| FY2019 | Feb 28, 2018 | 0 | May 28, 2019 |
| FY2018 | Feb 28, 2017 | 0 | May 24, 2018 |
| FY2017 | Feb 29, 2016 | 0 | May 26, 2017 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | 0 | May 28, 2025 |
| FY2025 | Feb 29, 2024 | 0 | May 28, 2025 |
| FY2024 | Feb 28, 2023 | 0 | May 23, 2024 |
| FY2023 | Feb 28, 2022 | 0 | May 25, 2023 |
| FY2022 | Feb 28, 2021 | 0 | May 24, 2022 |
| FY2021 | Feb 29, 2020 | 0 | May 28, 2021 |
| FY2020 | Feb 28, 2019 | 0 | May 29, 2020 |
| FY2019 | Feb 28, 2018 | 0 | May 28, 2019 |
| FY2018 | Feb 28, 2017 | 0 | May 24, 2018 |
| FY2017 | Feb 29, 2016 | 0 | May 26, 2017 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | 15.75M | May 28, 2025 |
| FY2025 | Feb 29, 2024 | 15.75M | May 28, 2025 |
| FY2024 | Feb 28, 2023 | 15.74M | May 23, 2024 |
| FY2023 | Feb 28, 2022 | 15.73M | May 25, 2023 |
| FY2022 | Feb 28, 2021 | 15.45M | May 24, 2022 |
| FY2021 | Feb 29, 2020 | 15.35M | May 28, 2021 |
| FY2020 | Feb 28, 2019 | 15.20M | May 29, 2020 |
| FY2019 | Feb 28, 2018 | 14.99M | May 28, 2019 |
| FY2018 | Feb 28, 2017 | 14.96M | May 24, 2018 |
| FY2017 | Feb 29, 2016 | 14.96M | May 26, 2017 |